Smyth S S, Parise L V
Department of Pharmacology, University of North Carolina, Chapel Hill 27599-7365.
Biochem J. 1993 Jun 15;292 ( Pt 3)(Pt 3):749-58. doi: 10.1042/bj2920749.
The major platelet integrin, glycoprotein IIb-IIIa, binds soluble fibrinogen only after platelet activation. To investigate the mechanism by which platelets convert glycoprotein IIb-IIIa into a functional fibrinogen receptor, we characterized the opening and closing of fibrinogen-binding sites in isolated platelet membranes and compared the regulatory properties of membrane-bound glycoprotein IIb-IIIa with those of the detergent-solubilized receptor. Basal fibrinogen binding to the membranes possessed many of the properties of fibrinogen binding to activated platelets; however, less than 10% of glycoprotein IIb-IIIa in the membranes was capable of binding fibrinogen. Preincubating the membranes with either an activating glycoprotein IIb-IIIa antibody or alpha-chymotrypsin increased fibrinogen binding. In contrast, agents that require intracellular mediators, such as platelet agonists, guanine-nucleotide-binding-protein activators and purified protein kinase C, did not stimulate fibrinogen binding to the membranes, suggesting that cytosolic factor(s) may be required for activation of the receptor in platelets. Occupancy of glycoprotein IIb-IIIa in the membranes with RGD (Arg-Gly-Asp)-containing peptides reversibly exposed neoantigenic epitopes and fibrinogen-binding sites in the receptor. These conformational changes required membrane fixation to be maintained following peptide removal. Similar results were obtained with purified glycoprotein IIb-IIIa incorporated into phospholipid vesicles, indicating that the resting state of the receptor is favoured in these environments. In contrast, when the conformation of detergent-solubilized glycoprotein IIb-IIIa was altered by exposure to RGD-containing peptides, the receptor remained active even after incorporation into phospholipid vesicles. These results demonstrate that platelet membranes are a useful model in which to study the regulation of glycoprotein IIb-IIIa and suggest that the environment surrounding the receptor may have a profound influence on this process.
主要的血小板整合素糖蛋白IIb-IIIa仅在血小板激活后才结合可溶性纤维蛋白原。为了研究血小板将糖蛋白IIb-IIIa转化为功能性纤维蛋白原受体的机制,我们对分离的血小板膜中纤维蛋白原结合位点的开放和关闭进行了表征,并将膜结合的糖蛋白IIb-IIIa的调节特性与去污剂溶解的受体的调节特性进行了比较。纤维蛋白原与膜的基础结合具有许多纤维蛋白原与活化血小板结合的特性;然而,膜中不到10%的糖蛋白IIb-IIIa能够结合纤维蛋白原。用激活糖蛋白IIb-IIIa的抗体或α-胰凝乳蛋白酶预孵育膜可增加纤维蛋白原结合。相反,需要细胞内介质的试剂,如血小板激动剂、鸟嘌呤核苷酸结合蛋白激活剂和纯化的蛋白激酶C,不会刺激纤维蛋白原与膜的结合,这表明血小板中受体的激活可能需要细胞溶质因子。用含RGD(精氨酸-甘氨酸-天冬氨酸)的肽占据膜中的糖蛋白IIb-IIIa会可逆地暴露受体中的新抗原表位和纤维蛋白原结合位点。这些构象变化在去除肽后需要膜固定来维持。将纯化的糖蛋白IIb-IIIa掺入磷脂囊泡中也得到了类似的结果,表明在这些环境中受体的静止状态更有利。相反,当去污剂溶解的糖蛋白IIb-IIIa的构象通过暴露于含RGD的肽而改变时,即使掺入磷脂囊泡后受体仍保持活性。这些结果表明血小板膜是研究糖蛋白IIb-IIIa调节的有用模型,并表明受体周围的环境可能对这一过程有深远影响。